University of Warwick -- The Universities of Warwick and Birmingham have been jointly awarded almost £20 million to develop the world-class medical research undertaken at both institutions into practical applications for patient care. The Regional Development Agency, Advantage West Midlands, has funded the Translational Medicine scheme as part of the Science City initiative, which draws together industry, business, education and the public sector, to establish the West Midlands region as a centre for world-class scientific research. The two Universities have led different elements of the Translational Medicine scheme to take research from basic science into new treatments for the region’s patients. The University of Warwick has been awarded £9.875 million to take new medical developments into clinical trials, significantly expanding international quality clinical trials activity in the region. This part of the project will help to fund the building of a new Clinical Trials building at Warwick and the refurbishment of facilities at the University of Birmingham, enabling expansion of existing clinical trials activity.
